|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization expense | |||||
| Amortization of debt issuance costs | |||||
| Provision for expected credit losses | |||||
| Change in fair value of common stock warrants | |||||
| Operating lease and other impairment charges | |||||
| Amortization of discount or (accretion of premium) on short-term investments | |||||
| Benefit for deferred income taxes | |||||
| Loss from equity method investments | |||||
| Stock-based compensation expense | |||||
| Loss on extinguishment of debt | |||||
| Acquired in-process research and development expenses | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Prepaid and other current assets | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Employee-related liabilities | |||||
| Deferred revenue | |||||
| Operating leases and other current liabilities | |||||
| Other long-term liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturities and redemptions of short-term investments | |||||
| Purchases of property and equipment | |||||
| Acquisition of in-process research and development | |||||
| Purchases of equity investments, strategic investments, and intangible assets | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities | |||||
| Proceeds from issuance of convertible senior notes due 2029, net of $9,400 debt issuance costs | |||||
| Repurchase of $246,740 principal amount of convertible senior notes due 2025 | |||||
| Principal payments on convertible senior notes due 2025 | |||||
| Payment for capped call transactions related to convertible senior notes due 2029 | |||||
| Repurchase and retirement of common stock | |||||
| Proceeds from exercise of common stock warrants | |||||
| Cash used to settle withholding taxes on vested restricted stock, net of proceeds from issuance of common stock under Company stock plans | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental schedule of non-cash investing and financing activities | |||||
| Operating lease right-of-use assets obtained in exchange for operating lease obligations | |||||
| Purchases of property and equipment included in accounts payable and accrued expenses | |||||
| Intangible costs in other long-term liabilities | |||||
Loading...